Cranbury, United States
Rocket Pharmaceuticals is a fully-integrated, clinical-stage company with a mission of seeking gene therapy cures. Founded in 2015 and headquartered in the United States, the company positions itself at the intersection of Biotechnology, Health Care, and Pharmaceutical industries.
Known for its dedication to both pipeline advancement and team well-being, Rocket Pharma emphasizes the importance of collaborative, hands-on contributions from its team members. The company is driven by scientific innovation and has gained increasing recognition as a leading player in biotechnology. Beyond its mission-driven culture, Rocket Pharmaceuticals offers a competitive compensation package that includes a substantial 401K match and stock options, along with excellent health benefits.
On 12 September 2023, Rocket Pharmaceuticals continued its growth trajectory with a Post-IPO Equity investment, highlighting continued investor confidence in its strategic direction and scientific capabilities.
